Xact Kapitalforvaltning’s Amicus Therapeutics FOLD Stock Holding History

Xact Kapitalforvaltning’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$455K	Hold	49,241	–	–	0.01%	806
2019 Q4	$480K	Hold	49,241	–	–	0.01%	982
2019 Q3	$395K	Buy	49,241 +15,400	+46%	+$167K	0.01%	1053
2019 Q2	$422K	Hold	33,841	–	–	0.01%	1022
2019 Q1	$460K	Hold	33,841	–	–	0.01%	965
2018 Q4	$324K	Buy	33,841 +4,600	+16%	+$50.6K	0.01%	1185
2018 Q3	$354K	Hold	29,241	–	–	0.01%	1242
2018 Q2	$457K	Buy	29,241 +3,600	+14%	+$54.4K	0.01%	999
2018 Q1	$386K	Buy	25,641 +10,400	+68%	+$158K	0.01%	1008
2017 Q4	$219K	Buy	+15,241	New	+$209K	0.01%	1188

Other funds holding FOLD

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Xact Kapitalforvaltning's FOLD Position: Q1 2020 in Review

Xact Kapitalforvaltning held its Amicus Therapeutics (FOLD) position steady in Q1 2020 at 49,241 shares worth $455K. The position accounts for 0.01% of the portfolio, ranked #806.

Xact Kapitalforvaltning first reported a position in FOLD in Q4 2017 and has held it in 10 quarters since. The position peaked at $480K in Q4 2019. 203 funds tracked by Wall St. Rank hold FOLD as of Q1 2020.

Xact Kapitalforvaltning held 49,241 shares of Amicus Therapeutics worth $455K as of Q1 2020.
Xact Kapitalforvaltning left its Amicus Therapeutics share count unchanged in Q1 2020.
Amicus Therapeutics made up 0.01% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #806 holding.
Xact Kapitalforvaltning first reported a position in Amicus Therapeutics in Q4 2017 and has held it in 10 quarters since.
Xact Kapitalforvaltning's Amicus Therapeutics position peaked at $480K in Q4 2019.
203 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.